Archives

by in
Entry Author Date Location
BioCryst Bets on New Ebola Drug to Fight Bioterror, Outbreak Threats 07/24/14 Raleigh Durham
Antigenics Expands Experimental Cancer Treatment, Novartis Adds to Cambridge Presence, Boston Scientific Sells Unit to Stryker, & More Boston-Area Life Sciences News 10/29/10 Boston
New CEO for Idenix 10/28/10 Boston
ZymoGenetics Drug For Hepatitis C Kills Virus with Minimal Side Effects 11/03/08 Seattle
Page 1 of 1